Adjuvant pembrolizumab gets positive opinion from the European CHMP
We have just learnt that the Committee for Medicinal Products [...]
Nivolumab/cabozantinib combination approved in EU for first-line kidney cancer treatment
The European Commission has approved the use of the nivolumab [...]
European Commission approves avelumab plus axitinib combination for the first-line treatment of advanced kidney cancer
Based on the findings from the pivotal phase III JAVELIN [...]
European Commission approves pembrolizumab plus axitinib combination for first-line treatment of advanced kidney cancer
Based on the findings from the pivotal phase 3 KEYNOTE-426 [...]
European Commission approves cabozantinib for first-line kidney cancer
The European Commission has approved cabozantinib (Cabometyx) for the first-line [...]
